Proceedings of the National Academy of Sciences · 2010 · 189 citations · 32 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyOncogenesCancer Stem Cell BiologyCancer Stem CellsHepatocellular CarcinomaLiver CancerMicrorna BiologyMicrorna-mediated RegulationExpression ProfilingHepatic Progenitor CellsLiver Progenitor CellsMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMyc InhibitorsProgenitor Cells
Myc activation is implicated in the development of hepatoblastoma, a rare embryonal liver cancer derived from progenitor cells. ChIP and Myc‑inhibition assays in hepatoma cells showed that Myc differentially regulates the miR‑371–3 and miR‑100/let‑7a‑2/miR‑125b‑1 clusters in opposite directions. The study demonstrated that Myc‑driven opposing regulation of these miRNA clusters promotes aggressive, stem‑cell‑like tumor phenotypes, and that a four‑miRNA signature derived from them accurately stratifies hepatoblastoma and hepatocellular carcinoma patients for poor prognosis.
Myc activation has been implicated in the pathogenesis of hepatoblastoma (HB), a rare embryonal neoplasm derived from liver progenitor cells. Here, microRNA (miR) expression profiling of 65 HBs evidenced differential patterns related to developmental stage and Myc activity. Undifferentiated aggressive HBs overexpressed the miR-371–3 cluster with concomitant down-regulation of the miR-100/let-7a-2/miR-125b-1 cluster, evoking an ES cell expression profile. ChIP and Myc inhibition assays in hepatoma cells demonstrated that both miR clusters are regulated by Myc in an opposite manner. We show that the two miR clusters exert antagonistic effects on cell proliferation and tumorigenicity. Moreover, their combined deregulation cooperated in modulating the hepatic tumor phenotype, implicating stem cell-like regulation of Myc-dependent miRs in poorly differentiated HBs. Importantly, a four-miR signature representative of these clusters efficiently stratified HB patients, and when applied to 241 hepatocellular carcinomas (HCCs), it identified invasive tumors with a poor prognosis. Our data argue that Myc-driven reprogramming of miR expression patterns contributes to the aggressive phenotype of liver tumors originating from hepatic progenitor cells.
32
A microRNA polycistron as a potential human oncogene
Lin He, J. Michael Thomson, Michael T. Hemann et al. · Nature · 2005 · 3.5K citations
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota, Raghu R. Chivukula, Kathryn A. O’Donnell et al. · Cell · 2009 · 1.7K citations · Full text
Widespread microRNA repression by Myc contributes to tumorigenesis
Tsung-Cheng Chang, Duonan Yu, Yun‐Sil Lee et al. · Nature Genetics · 2007 · 1.3K citations · Full text